中文
Subsidiary Companies
feed
Animal Protection
Offspring
Seedling
Machinery Tools
Trade
Feed Premix
Pet Nutrition

Sichuan Hailinger Biopharmaceutical Co., Ltd.

Company Profile

Sichuan Hailinger Biopharmaceutical Co., Ltd. ( "the Company") is a holding subsidiary of Guangdong HAID Group Co., Ltd. (stock code: 002311), a leading public company in agriculture and animal husbandry industry. It is located in Chengdu (Both Sides of the Taiwan Straits) Science and Technology Industrial Park. The predecessor company founded in 1958 was the state-run veterinary biological pharmaceutical factory in Sichuan Province.
 

The company is one of the high-tech enterprises specialized in research and development, production, sales and service on veterinary biological products. It covers an area of more than 70 mu with the construction area of about 25,000 square meters and the total assets of 180 million RMB. In February 1, 2015, it has obtained the certification of the Ministry of Agriculture veterinary drug GMP dynamic re-test. Currently, it has two production plants with a total of 10 production lines, which contains two international leading design concepts of cell suspension culture of live vaccine and inactivated vaccine production line.

 

The company is a sentinel production enterprise of the Ministry of Agriculture for "the Government procurement of swine fever series of live vaccines (passaged cell source, cell source and spleen source) and brucellosis live vaccine (S2 strains and A19 strains)".
 

The company wholeheartedly practices the mission of "becoming China's major suppliers of high-quality animal vaccines and high-end customized service providers", introduced key positions in a number of industry veteran professionals and invested 35.6 million RMB to complete the upgrading of key equipment and processes to enhance professional and industrial manufacturing level. The company's R & D and technical support services is provided by HAID Group’s Research Institute of Animal Husbandry and Veterinary Research (hereinafter referred to as "Research Institute"). The chairman of the company is personally the chief scientist and the president of the institute. The company has a 36 full-time employees who research and develop livestock and poultry vaccine, including 12 doctors, 18 master's, with 30 million worth of equipment and facilities for vaccine development and testing. In October 12, 2015, it was designed as "The first batch of new R & D institutions in Guangdong Province." by the Guangdong Provincial Science and Technology Department.
 

Adhering to the business philosophy of "user-centric", our company provides customers with improved products and services in terms of excellence in product quality, fast and safe cold chain distribution services and professional and efficient technical support. In order to continue to provide higher quality services, the Group invested annual profit of not less than 10% into the two scientific research systems for the R & D of new technologies, new processes and new product. In August 2015 , the project - "Porcine circovirus type 2 (PCV-2) peptide vaccine development" committed by Research Institute to the Office of the Guangdong Provincial Science and Technology Research has been got clinical trial approval by the Ministry of Agriculture Veterinary Drug Evaluaton Office, and has entered the clinical trial stage. The product is expected to officially enter the market in the second half of 2016.  At the same time, pseudorabies live vaccines (mutant), CSF-pseudorabies combined live vaccines, swine epidemic diarrhea virus inactivated vaccine (epidemic strain), gene tagged Brucella live vaccine, duck serositis poly Inactivated vaccine and other new products have also entered the clinical trial declaration stage. The Research Institute has also developed number of technologies including mucosal immune adjuvant, heat protection agent, peptide genetic engineering technology, vaccine purification process, polyvalent multivalent vaccine, ELISA antibody detection kits for PRRSV, CSF, pseudorabies. We believe that in the near future we will be able to provide high-quality, diversified products and services for animal framing groups and farmers.      

Finally, it is very honored to get your attention and look forward to the opportunity to serve you. We would like to express our heartfelt thanks!

 
Sichuan Hailinger Biological Pharmaceutical Co., Ltd
                                      
                                     

 

×
Haid Wechat
Links